2 results
Not approvedWill not start
Determine the prolonged effect of a 12 week physical exercise program in congestive heart failure patients.
Approved WMOPending
The HOPE-3 trial will evaluate the effects of lipid modification with rosuvastatin and of blood pressure lowering with candesartan/hydrochlorothiazide (HCT) and their combination in a wide range of middle aged people, who are at average risk for…